Stereotaxis to Present at 37th Annual Roth Conference

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the 37^th Annual ROTH Conference in Dana Point, California.

Mr. Fischel will be available for one-on-one meetings on Monday, March 17^th, …

Full story available on Benzinga.com